Ixazomib Citrate Clinical Trials
2 recruitingDrug
Phase 21Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
Refractory AL AmyloidosisRecurrent AL Amyloidosis
National Cancer Institute (NCI)24 enrolled16 locationsNCT04847453
Recruiting
Phase 2
Trial of Ixazomib for Kaposi Sarcoma
Kaposi SarcomaSkin
AIDS Malignancy Consortium41 enrolled11 locationsNCT04305691